Immunity against rabies virus in individuals after post exposure vaccination in Northern Pakistan
Abstract
Objective: To assess the degree of immunity in persons against Rabies virus after post exposure prophylaxis.
Study Design: Descriptive cross-sectional study.
Place and Duration of the study: The study was conducted in Virology Department, Armed Forces Institute of Pathology, Rawalpindi from 1st Jan 2012 to 31st Dec 2013.
Patients and Methods: Patients reporting to AFIP for testing of antibodies against Rabies virus after post exposure vaccination were included in the study. A proforma was used to record incident of exposure and the action taken. The IgG antiglycoprotein antibodies were detected in serum samples using Platelia TM Rabies II kit of Bio Rad. Platelia is an indirect enzyme linked immunosorbent assay based on solid phase enzyme immunoassay for detecting protective antibodies against rabies virus.
Results: Out of a total of 144 patients, 115 (79.8%) were males and 29 (20.1%) were females. The age of the patients ranged from 3 to 77 years with a mean of 27.03+19.01 years. Protective antibodies were detected in 118 (81.9%) patients, while antibodies were not detected in 26 (18.5%) cases.
Conclusion: A majority of males were observed in this study as compared to females. Rabies vaccine was found to be effective in producing protective antibodies against the virus in most patients. People failing to produce antibodies must be offered revaccination and further evaluation.
Keywords: Rabies virus, Rabies vaccine, Immunity, Antibodies.
Â
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Muhammad Ali Rathore, Eijaz Ghani, Mommana Ali Rathore

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
